ALNY
ALNYLAM PHARMACEUTICALS, INC.
NASDAQ · Healthcare · Biotechnology · US
$233.29
+0.63%Forward multiples
Based on analyst estimates
- P/E forward
- 25.56x
- P/E 2026E
- 35.26x
- P/E 2027E
- 23.81x
- P/E 2028E
- 19.38x
- P/S forward
- 4.65x
Trailing multiples
Trailing twelve months
- P/E TTM
- 38.24x
- PEG TTM
- 0.77x
- Price / book
- 23.05x
- Price / sales
- 6.50x
- Price / cash flow
- 49.20x
Enterprise value
- Enterprise value
- $29.2B
- EV / sales
- 6.07x
- EV / EBITDA
- 25.35x
- EV / EBIT
- 29.18x
- Market cap
- $31.2B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026